271 related articles for article (PubMed ID: 24626656)
21. Skin lesions--an indicator of disease activity in systemic lupus erythematosus?
Zecević RD; Vojvodić D; Ristić B; Pavlović MD; Stefanović D; Karadaglić D
Lupus; 2001; 10(5):364-7. PubMed ID: 11403268
[TBL] [Abstract][Full Text] [Related]
22. Oral manifestations of patients with lupus erythematosus.
Brennan MT; Valerin MA; Napeñas JJ; Lockhart PB
Dent Clin North Am; 2005 Jan; 49(1):127-41, ix. PubMed ID: 15567365
[TBL] [Abstract][Full Text] [Related]
23. Response criteria for cutaneous SLE in clinical trials.
Ad Hoc Committee Response Criteria For Cutaneous SLE
Clin Exp Rheumatol; 2007; 25(5):666-71. PubMed ID: 18078611
[TBL] [Abstract][Full Text] [Related]
24. Modulation of Immune Cells as a Therapy for Cutaneous Lupus Erythematosus.
Soto JA; Melo-González F; Riedel CA; Bueno SM; Kalergis AM
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142624
[TBL] [Abstract][Full Text] [Related]
25. Keratinocyte and lymphocyte apoptosis: relation to disease outcome in systemic lupus erythematosus patients with and without cutaneous manifestations.
Salem SA; Farouk HM; Mostafa AA; Hassan IM; Osman WM; Al-Shamy HA; Assaf NY
Eur J Dermatol; 2010; 20(1):35-41. PubMed ID: 19919906
[TBL] [Abstract][Full Text] [Related]
26. [Erythema elevatum diutinum--a rare variant of skin changes in systemic lupus erythematosus].
Schulze P; Audring H; Sönnichsen N
Dermatol Monatsschr; 1989; 175(10):628-34. PubMed ID: 2591614
[TBL] [Abstract][Full Text] [Related]
27. Pathogenetic mechanisms and treatment of cutaneous lupus erythematosus.
Werth VP; Dutz JP; Sontheimer RD
Curr Opin Rheumatol; 1997 Sep; 9(5):400-9. PubMed ID: 9309195
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous lupus erythematosus: a review.
Patel P; Werth V
Dermatol Clin; 2002 Jul; 20(3):373-85, v. PubMed ID: 12170873
[TBL] [Abstract][Full Text] [Related]
29. [Cutaneous lupus erythematosus].
Sandreva T; Voss A; Bygum A
Ugeskr Laeger; 2015 Jul; 177(31):. PubMed ID: 26238007
[TBL] [Abstract][Full Text] [Related]
30. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications.
Chlebus E; Wolska H; Blaszczyk M; Jablonska S
J Am Acad Dermatol; 1998 Mar; 38(3):405-12. PubMed ID: 9520021
[TBL] [Abstract][Full Text] [Related]
31. Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.
Lu Q; Long H; Chow S; Hidayat S; Danarti R; Listiawan Y; Deng D; Guo Q; Fang H; Tao J; Zhao M; Xiang L; Che N; Li F; Zhao H; Lau CS; Ip FC; Ho KM; Paliza AC; Vicheth C; Godse K; Cho S; Seow CS; Miyachi Y; Khang TH; Ungpakorn R; Galadari H; Shah R; Yang K; Zhou Y; Selmi C; Sawalha AH; Zhang X; Chen Y; Lin CS
J Autoimmun; 2021 Sep; 123():102707. PubMed ID: 34364171
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous lesions in systemic lupus erythematosus.
Watson R
Med Clin North Am; 1989 Sep; 73(5):1091-111. PubMed ID: 2671534
[TBL] [Abstract][Full Text] [Related]
33. [Subacute cutaneous lupus erythematosus based on a study of 15 cases].
Marschalkó M; Dobozy E; Daróczy J; Gyimesi E; Horváth A
Orv Hetil; 1989 Dec; 130(49):2623-8. PubMed ID: 2689950
[TBL] [Abstract][Full Text] [Related]
34. Increased interleukin-9 levels in skin lesions from cutaneous lupus erythematosus patients may predict the progression to systemic lupus erythematosus.
Xie Y; Liu B; Wu Z
J Dermatol Sci; 2021 Jan; 101(1):78-80. PubMed ID: 33172731
[No Abstract] [Full Text] [Related]
35. Neuropsychiatric manifestations in an adolescent male with Rowell syndrome.
Kadiru RA; Hegde SP; Mithun HK; Rao AC
J Postgrad Med; 2021; 67(2):109-112. PubMed ID: 33835061
[TBL] [Abstract][Full Text] [Related]
36. The Cutaneous Spectrum of Lupus Erythematosus.
Ribero S; Sciascia S; Borradori L; Lipsker D
Clin Rev Allergy Immunol; 2017 Dec; 53(3):291-305. PubMed ID: 28752372
[TBL] [Abstract][Full Text] [Related]
37. A review of the evidence and cost of therapies for cutaneous lupus erythematosus.
Rosen JD; Paul S; Maderal A
Lupus; 2019 Jun; 28(7):799-805. PubMed ID: 31042129
[TBL] [Abstract][Full Text] [Related]
38. Invariant natural killer T cells are enriched at the site of cutaneous inflammation in lupus erythematosus.
Hofmann SC; Bosma A; Bruckner-Tuderman L; Vukmanovic-Stejic M; Jury EC; Isenberg DA; Mauri C
J Dermatol Sci; 2013 Jul; 71(1):22-8. PubMed ID: 23664188
[TBL] [Abstract][Full Text] [Related]
39. [Bullous systemic lupus erythematosus].
Teikemeier G; Kind P; Goerz G
Z Hautkr; 1988 Apr; 63(4):320-5. PubMed ID: 3291441
[TBL] [Abstract][Full Text] [Related]
40. Involvement of scalp and nails in lupus erythematosus.
Trüeb RM
Lupus; 2010 Aug; 19(9):1078-86. PubMed ID: 20693201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
